SE8406263D0 - PROCEDURE FOR THE PREPARATION OF A NEW MEDICINE USEFUL HEMIN ASSOCIATION - Google Patents

PROCEDURE FOR THE PREPARATION OF A NEW MEDICINE USEFUL HEMIN ASSOCIATION

Info

Publication number
SE8406263D0
SE8406263D0 SE8406263A SE8406263A SE8406263D0 SE 8406263 D0 SE8406263 D0 SE 8406263D0 SE 8406263 A SE8406263 A SE 8406263A SE 8406263 A SE8406263 A SE 8406263A SE 8406263 D0 SE8406263 D0 SE 8406263D0
Authority
SE
Sweden
Prior art keywords
hemin
preparation
association
procedure
new medicine
Prior art date
Application number
SE8406263A
Other languages
Swedish (sv)
Other versions
SE8406263L (en
SE457958B (en
Inventor
G D Ingberg
R L A Penttile
R O Tokola
R A Tenhunen
Original Assignee
Lekemedelsfabriken Medica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lekemedelsfabriken Medica Ab filed Critical Lekemedelsfabriken Medica Ab
Publication of SE8406263D0 publication Critical patent/SE8406263D0/en
Publication of SE8406263L publication Critical patent/SE8406263L/en
Publication of SE457958B publication Critical patent/SE457958B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A method for the preparation of a new, physiologically active, water-soluble complex compound of hemin arginate or hemin lysinate in which crystalline hemin and the amino acid L-arginine or L-lysine, in a molar proportion of 1:3, are allowed to react at room temperature under vigorous stirring for 10 to 15 hours in a solvent mixture of acetone and water 300:20 v/v. The hemin arginate or hemin lysinate thus formed is a powdery, stable compound suitable for use as raw material in tablets or capsules or as dry substance for preparation of injections for treatment of various types of anemia, particularly anemias associated with prophyria.
SE8406263A 1984-12-12 1984-12-10 WATER-SOLUBLE HEMIN ARGINATE OR HEMIN-LYSINATE SOCIETY, PROCEDURE FOR PREPARING THEREOF AND USING THEREOF FOR MANUFACTURE OF MEDICAL COMPOSITIONS SE457958B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08431398A GB2168354B (en) 1984-12-12 1984-12-12 Hemin compound

Publications (3)

Publication Number Publication Date
SE8406263D0 true SE8406263D0 (en) 1984-12-10
SE8406263L SE8406263L (en) 1986-06-11
SE457958B SE457958B (en) 1989-02-13

Family

ID=10571084

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8406263A SE457958B (en) 1984-12-12 1984-12-10 WATER-SOLUBLE HEMIN ARGINATE OR HEMIN-LYSINATE SOCIETY, PROCEDURE FOR PREPARING THEREOF AND USING THEREOF FOR MANUFACTURE OF MEDICAL COMPOSITIONS

Country Status (12)

Country Link
JP (1) JPH0647541B2 (en)
AT (1) AT389308B (en)
BE (1) BE901319A (en)
CA (1) CA1242713A (en)
CH (1) CH666273A5 (en)
DE (1) DE3446887C2 (en)
FR (1) FR2574662B1 (en)
GB (1) GB2168354B (en)
LU (1) LU85716A1 (en)
NL (1) NL192682C (en)
SE (1) SE457958B (en)
SU (1) SU1384188A3 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0645681B2 (en) * 1986-02-05 1994-06-15 美浜 久春 Modified hem
IT1245890B (en) * 1991-04-12 1994-10-25 Alfa Wassermann Spa PHARMACEUTICAL FORMULATIONS FOR ORAL USE GASTRORESANTS CONTAINING BILE ACIDS.
US7994217B2 (en) 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
RU2611636C1 (en) * 2016-02-25 2017-02-28 Федеральное государственное бюджетное образовательное учреждение высшего образования Новосибирский государственный аграрный университет Hematogen
RU2671633C1 (en) * 2017-11-30 2018-11-06 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Highly effective hematogen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912M (en) * 1963-07-24 1964-11-09 Rech S Pharma E R P H A R Soc Procaine hematoporphyrinate dihydrochloride.
JPS4930521A (en) * 1972-07-17 1974-03-19
JPS5144623A (en) * 1974-10-14 1976-04-16 Green Cross Corp CHUSHAYOASECHIRUSARICHIRUSANENNO SEIHO
DE2527158A1 (en) * 1975-06-18 1976-12-23 Herz Eberhard MEDICINAL PRODUCTS FOR THE TREATMENT OF INFECTIOUS DISEASES AND INFLAMMATION IN HUMAN AND VETERINAL MEDICINE THAT CANNOT BE DETECTED BY MICROORGANISMS
JPS6021570B2 (en) * 1978-07-04 1985-05-28 三共株式会社 Method for manufacturing high concentration preparations of DOPAs
JPS5780317A (en) * 1980-11-05 1982-05-19 Sumitomo Chem Co Ltd Preparation of pharmaceutical composition for injection
JPS57209211A (en) * 1981-06-18 1982-12-22 Shiseido Co Ltd Antimicrobial composition

Also Published As

Publication number Publication date
BE901319A (en) 1985-04-16
NL192682B (en) 1997-08-01
SU1384188A3 (en) 1988-03-23
DE3446887A1 (en) 1986-07-03
JPH0647541B2 (en) 1994-06-22
DE3446887C2 (en) 1994-05-05
JPS61172821A (en) 1986-08-04
GB8431398D0 (en) 1985-01-23
SE8406263L (en) 1986-06-11
ATA390784A (en) 1989-04-15
LU85716A1 (en) 1985-07-24
FR2574662B1 (en) 1990-03-02
NL8403782A (en) 1986-07-01
NL192682C (en) 1997-12-02
AT389308B (en) 1989-11-27
FR2574662A1 (en) 1986-06-20
GB2168354A (en) 1986-06-18
SE457958B (en) 1989-02-13
CA1242713A (en) 1988-10-04
GB2168354B (en) 1988-12-07
CH666273A5 (en) 1988-07-15

Similar Documents

Publication Publication Date Title
HUT45236A (en) Process for producing new benzimidazole derivatives
CA1139768A (en) Mixed salts of essential or semi-essential amino acids and nitrogen-free analogues thereof and uses in treatment of renal and hepatic disorders
NO176101C (en) Analogous Process for the Preparation of Therapeutically Active N- (3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin) carboxamide derivatives
NO169347C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE POLYPEPTIDES
ES2070994T3 (en) DOPAMINE PROFARMACO.
HUP9903455A2 (en) Stable,non-hygroscopic salts of l(-)carnitine and alkanoyl l(-) carnitines,a process for their preparation and solid,orally administrable compositions containing such salts
IL84409A0 (en) Imidazolidinone derivatives,their preparation and pharmaceutical compositions containing them
US3275643A (en) Allantoin-pantothenate compounds
SE8406263L (en) PROCEDURE FOR THE PREPARATION OF A NEW MEDICINE USEFUL HEMIN ASSOCIATION
US4973553A (en) Salt or organogermanium compound and medicine containing the same
WO1986002555A3 (en) Amino acid solution-containing drug for the treatment of cancerous diseases and preparation process thereof
NO883520D0 (en) PROCEDURE FOR THE PREPARATION OF AN INJECTION PREPARATION.
GB1333524A (en) Penicilloic acid derivatives
KR0144442B1 (en) Water soluble bithmuth compound and process of preparation forthereof
DK220088D0 (en) THIADIASOLGUANIDINES, PROCEDURES FOR PREPARING THEREOF AND AFRMACEUTICAL PREPARATIONS CONTAINING THESE RELATIONSHIPS
DK583884A (en) PROCEDURE FOR MAKING A HOME RELATIONSHIP
EP0157284A3 (en) Theophylline-7-acetic acid ester of d,l-trans-sobrerol having mucosecretolytic-fluidizing and antibronchospastic activity, a process for its preparation and pharmaceutical compositions thereof
SU606242A1 (en) "dimotziphon" anti-leprose preparation
Hay et al. The uncatalysed and the copper (II) promoted hydrolysis of 4-nitrophenyl L-leucinate
JPS62252793A (en) Organic germanium compound and drug containing same
GB2073192A (en) Cefadroxil Salts
EP0010830A3 (en) Dehydropeptides
TH9830EX (en) Pirolo's derivatives (2, 1 - B) thiazole
JPS55164668A (en) Alpha-amino-beta-chloroethane-sulfonic acid or its salt
TH18739EX (en) Risperidone Pamoet

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8406263-7

Format of ref document f/p: F

NUG Patent has lapsed
NUG Patent has lapsed